2.5  0.06 (2.46%)		04-23 16:00
Open: 2.44 High: 2.52 Volume: 44,119		Pre. Close: 2.44 Low: 2.44 Market Cap: 174(M)

Short term
Mid term
Targets	6-month :	3.39	1-year :	3.76
Resists	First :	2.91	Second :	3.22
Pivot price	2.75
Supports	First :	2.41	Second :	2
MAs	MA(5) :	2.56	MA(20) :	2.8
	MA(100) :	3	MA(250) :	3.37
MACD	MACD :	-0.2	Signal :	-0.1
%K %D	K(14,3) :	8.3	D(3) :	3.9
RSI	RSI(14): 26.4
52-week	High :	4.8	Low :	2.41

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ DRTS ] has closed above bottom band by 7.0%. Bollinger Bands are 50.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 0 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	2.53 - 2.54	2.54 - 2.56
Low:	2.4 - 2.42	2.42 - 2.44
Close:	2.47 - 2.5	2.5 - 2.53

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.

Fri, 12 Apr 2024
Alpha Tau Medical Ltd. (NASDAQ:DRTS) Sees Significant Growth in Short Interest - MarketBeat

Tue, 26 Mar 2024
DRTS Stock Quote Price and Forecast - CNN

Mon, 25 Mar 2024
Alpha Tau to Present at the Jefferies Radiopharma Innovation Summit - Yahoo Finance

Thu, 07 Mar 2024
Alpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate Update - Yahoo Finance

Mon, 26 Feb 2024
Alpha Tau to Participate in Barclays 26th Annual Global Healthcare Conference - Yahoo Finance

Sat, 13 Jan 2024
Alpha Tau Medical Ltd. (NASDAQ:DRTS) most popular amongst retail investors who own 58%, insiders hold 22% - Yahoo Finance

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares Out	70 (M)
Shares Float	52 (M)
Held by Insiders	25.7 (%)
Held by Institutions	2.7 (%)
Shares Short	57 (K)
Shares Short P.Month	28 (K)

EPS	-0.42
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	1.21
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	-19.7 %
Return on Equity (ttm)	-30.7 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	-0.5
Qtrly Earnings Growth	0 %
Operating Cash Flow	-18 (M)
Levered Free Cash Flow	-19 (M)

PE Ratio	-5.96
PEG Ratio	0
Price to Book value	2.06
Price to Sales	0
Price to Cash Flow	-9.7

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.